Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy-Reference-Cited by-同舟云学术

Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy

Published:2024-01 Issue:1 Volume:30 Page:116.e1-116.e12
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Infante Maria-Stefania,Nemirovsky David,Devlin Sean,DeWolf Susan,Tamari Roni,Dahi Parastoo B.,Lee Yeon Joo,Chung David J.,Politikos Ioannis,Barker Juliet,Giralt Sergio A.,Babady N. Esther,Ramanathan Lakshmi,Papanicolaou Genovefa A.,Seo Susan,Kamboj Mini,Perales Miguel-Angel,Shah Gunjan L.

Funder

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference50 articles.

1. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience;Shah;Br J Haematol,2020

2. Survival study of hospitalized patients with concurrent Covid-19 and haematological malignancies;Martín-Moro;Br J Haematol,2020

3. COVID-19 in persons with haematological cancers;He;Leukemia,2020

4. Clinical outcome of coronavirus disease 2019 in haemato-oncology patients;Aries;Br J Haematol,2020

5. Outcome of COVID-19 in allogeneic stem cell transplant recipients: results from the EPICOVIDEHA registry;Busca;Front Immunol,2023

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in the immunocompromised host;COVID-19: An Update;2024-09-01

2. COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics;Transplantation and Cellular Therapy;2024-08

3. The Impact of Prior COVID-19 on Noninfectious Endothelial Complications Following Allogeneic Hematopoietic Stem Cell Transplantation;Clinical Infectious Diseases;2024-06-05

4. SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study;Clinical Infectious Diseases;2024-05-27

5. Current understanding and management of CAR T cell-associated toxicities;Nature Reviews Clinical Oncology;2024-05-20